From the Department of Physiology, Medical College of Georgia (M.A., O.R., E.E.G., J.B.M., P.O., M.W.B., J.C.S.), Augusta University.
Department of Oral Biology (B.B.), Augusta University.
Hypertension. 2019 Dec;74(6):1524-1531. doi: 10.1161/HYPERTENSIONAHA.119.13477. Epub 2019 Oct 28.
Necrosis is a pathological form of cell death that induces an inflammatory response, and immune cell activation contributes to the development and maintenance of hypertension. Necrosis was measured in kidney, spleen, and aorta of 12- to 13-week-old male and female SHRs (spontaneously hypertensive rats); male SHRs had greater renal necrotic cell death than female SHRs. Because male SHRs have a higher blood pressure (BP) and a more proinflammatory T-cell profile than female SHRs, the current studies tested the hypothesis that greater necrotic cell death in male SHRs exacerbates increases in BP and contributes to the proinflammatory T-cell profile. Male and female SHRs were randomized to receive vehicle or Necrox-5-a cell permeable inhibitor of necrosis-from 6 to 12 weeks of age or from 11 to 13 weeks of age. In both studies, Necrox-5 decreased renal necrosis and abolished the sex difference. Treatment with Necrox-5 beginning at 6 weeks of age attenuated maturation-induced increases in BP in male SHR; BP in female SHR was not altered by Necrox-5 treatment. Necrox-5 decreased proinflammatory renal T cells in both sexes, although sex differences were maintained. Administration of Necrox-5 for 2 weeks in SHR with established hypertension resulted in a small but significant decrease in BP in males with no effect in females. These results suggest that greater necrotic cell death in male SHR exacerbates maturation-induced increases in BP with age contributing to sex differences in BP. Moreover, although necrosis is proinflammatory, it is unlikely to explain sex differences in the renal T-cell profile.
细胞坏死是一种病理性的细胞死亡形式,会引发炎症反应,而免疫细胞的激活有助于高血压的发展和维持。研究人员在 12-13 周龄的雄性和雌性 SHR(自发性高血压大鼠)的肾脏、脾脏和主动脉中测量了坏死程度;雄性 SHR 的肾脏坏死细胞死亡程度大于雌性 SHR。由于雄性 SHR 的血压(BP)高于雌性 SHR,且 T 细胞炎症反应更明显,因此本研究假设雄性 SHR 中更多的坏死细胞死亡会加剧 BP 的升高,并导致 T 细胞炎症反应更明显。研究人员将雄性和雌性 SHR 随机分为接受 vehicle(对照)或 Necrox-5(一种可透过细胞膜的坏死抑制剂)处理的组别,给药时间分别为 6-12 周龄或 11-13 周龄。在这两项研究中,Necrox-5 均可降低肾脏坏死程度并消除性别差异。从 6 周龄开始用 Necrox-5 治疗可减弱雄性 SHR 成熟诱导的 BP 升高;但 Necrox-5 处理对雌性 SHR 的 BP 没有影响。Necrox-5 降低了两性的促炎性肾脏 T 细胞,但仍维持了性别差异。在已经患有高血压的 SHR 中给予 Necrox-5 治疗 2 周,可使雄性 SHR 的 BP 出现小但有统计学意义的下降,而对雌性 SHR 则无影响。这些结果表明,雄性 SHR 中更多的坏死细胞死亡会加剧与年龄相关的成熟诱导的 BP 升高,导致 BP 的性别差异。此外,尽管坏死是炎症性的,但它不太可能解释肾脏 T 细胞表型的性别差异。